"The research profiles of our two institutions are suitable for generating synergy effects and mutually optimizing resources and competencies," added MDC Administrative Director Prof. Heike Graßmann. Both institutions want to jointly develop medical technology, especially in diagnostic and interventional imaging. The partners see the more intensive scientific cooperation as a long-term task. In addition to research, translation and teaching, both contract partners named the promotion of young scientists as an important concern.
Specifically, the aim is to use third-party funding to establish a platform for magnetic resonance imaging (MRI) together with academic and industrial partners from both sides. This aims to define the future of the technology. In addition, the two institutions want to organize joint symposia and summer schools and set up an incubator for start-ups.
The MDC and the OVGU are already involved in the "Artificial Intelligence in Digital Health (AIDHeal)" network together with Berlin and Potsdam universities. "Artificial intelligence is a technology driver for modern medical imaging. That is why we link developers and users in the AIDHeal network to increase the international visibility and competitiveness of 'Digital Healthcare, made in Germany'," said Prof. Thoralf Niendorf, who heads the Experimental Ultra-High Field MR group at the MDC.
"The complementary expertise of both locations, i.e. the excellent basic research of the MDC and the transfer-oriented research combined with the start-ups that have already emerged at the STIMULATE research campus, are key to the continuous translation of solutions into society," said the spokesperson of the Magdeburg research campus, Prof. Georg Rose. Medical imaging and translational application are the focus, although socio-political issues are also to be considered, which methodologically require increased interdisciplinarity.
MEDICA-tradefair.com; Source: Otto von Guericke University of Magdeburg
